West Pharmaceutical Services, Inc. (WST)
:WST
US Market
Advertisement

West Pharmaceutical Services (WST) Ratios

Compare
859 Followers

West Pharmaceutical Services Ratios

WST's free cash flow for Q3 2025 was $0.36. For the 2025 fiscal year, WST's free cash flow was decreased by $ and operating cash flow was $0.21. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.87 2.88 3.70 2.93 2.73
Quick Ratio
2.18 2.24 2.90 2.30 2.09
Cash Ratio
0.99 1.27 1.72 1.28 1.22
Solvency Ratio
0.62 0.77 0.76 0.80 0.48
Operating Cash Flow Ratio
1.09 1.16 1.39 0.98 0.94
Short-Term Operating Cash Flow Coverage
30.30 5.79 39.78 10.92 38.10
Net Current Asset Value
$ 769.00M$ 987.90M$ 987.60M$ 763.60M$ 434.40M
Leverage Ratios
Debt-to-Assets Ratio
0.07 0.08 0.09 0.10 0.12
Debt-to-Equity Ratio
0.10 0.11 0.12 0.14 0.18
Debt-to-Capital Ratio
0.09 0.10 0.11 0.12 0.15
Long-Term Debt-to-Capital Ratio
0.06 0.02 0.07 0.08 0.12
Financial Leverage Ratio
1.35 1.33 1.35 1.42 1.51
Debt Service Coverage Ratio
27.44 5.05 29.62 12.98 23.92
Interest Coverage Ratio
1.05K 75.11 92.91 104.49 59.84
Debt to Market Cap
0.01 <0.01 0.01 <0.01 0.01
Interest Debt Per Share
4.20 4.28 4.38 4.47 4.50
Net Debt to EBITDA
-0.42 -0.65 -0.65 -0.49 -0.55
Profitability Margins
Gross Profit Margin
35.59%38.28%39.36%41.52%35.76%
EBIT Margin
20.05%23.97%23.82%26.74%19.07%
EBITDA Margin
25.52%28.62%30.76%31.61%24.77%
Operating Profit Margin
20.91%22.92%25.43%26.57%18.95%
Pretax Profit Margin
20.44%23.66%23.55%26.45%18.69%
Net Profit Margin
16.30%20.12%20.30%23.37%16.13%
Continuous Operations Profit Margin
16.30%20.12%20.30%23.37%16.13%
Net Income Per EBT
79.72%85.01%86.17%88.37%86.27%
EBT Per EBIT
97.77%103.25%92.63%99.55%98.62%
Return on Assets (ROA)
11.98%15.50%16.20%19.97%12.39%
Return on Equity (ROE)
17.33%20.60%21.82%28.34%18.67%
Return on Capital Employed (ROCE)
18.18%21.41%23.69%27.66%17.77%
Return on Invested Capital (ROIC)
14.40%16.85%19.48%23.17%14.41%
Return on Tangible Assets
12.33%16.01%16.78%20.81%13.05%
Earnings Yield
2.45%2.27%3.35%1.90%1.65%
Efficiency Ratios
Receivables Turnover
4.62 5.76 5.69 5.79 5.57
Payables Turnover
7.60 7.51 8.13 7.13 6.47
Inventory Turnover
4.44 4.19 4.22 4.38 4.29
Fixed Asset Turnover
0.91 1.95 2.29 2.51 2.12
Asset Turnover
0.73 0.77 0.80 0.85 0.77
Working Capital Turnover Ratio
2.67 2.21 2.27 2.81 2.70
Cash Conversion Cycle
113.15 101.91 105.72 95.26 94.14
Days of Sales Outstanding
78.93 63.35 64.15 63.03 65.51
Days of Inventory Outstanding
82.26 87.15 86.48 83.41 85.04
Days of Payables Outstanding
48.04 48.60 44.91 51.19 56.40
Operating Cycle
161.20 150.50 150.63 146.45 150.54
Cash Flow Ratios
Operating Cash Flow Per Share
9.60 10.45 9.73 7.85 6.39
Free Cash Flow Per Share
5.24 5.58 5.91 4.44 4.03
CapEx Per Share
4.35 4.87 3.83 3.41 2.36
Free Cash Flow to Operating Cash Flow
0.55 0.53 0.61 0.57 0.63
Dividend Paid and CapEx Coverage Ratio
1.85 1.85 2.14 1.92 2.12
Capital Expenditure Coverage Ratio
2.20 2.15 2.54 2.30 2.71
Operating Cash Flow Coverage Ratio
2.29 2.51 2.28 1.80 1.45
Operating Cash Flow to Sales Ratio
0.23 0.26 0.25 0.21 0.22
Free Cash Flow Yield
1.90%1.58%2.51%0.95%1.42%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
40.96 44.09 29.89 52.73 60.48
Price-to-Sales (P/S) Ratio
6.64 8.87 6.07 12.32 9.75
Price-to-Book (P/B) Ratio
6.60 9.08 6.52 14.94 11.29
Price-to-Free Cash Flow (P/FCF) Ratio
52.86 63.12 39.85 105.55 70.23
Price-to-Operating Cash Flow Ratio
29.03 33.69 24.19 59.75 44.31
Price-to-Earnings Growth (PEG) Ratio
39.32 31.58 -2.61 0.58 1.40
Price-to-Fair Value
6.60 9.08 6.52 14.94 11.29
Enterprise Value Multiple
25.60 30.35 19.07 38.49 38.83
Enterprise Value
19.63B 25.62B 16.93B 34.46B 20.65B
EV to EBITDA
25.50 30.35 19.07 38.49 38.83
EV to Sales
6.51 8.68 5.87 12.17 9.62
EV to Free Cash Flow
51.79 61.80 38.54 104.23 69.26
EV to Operating Cash Flow
28.30 32.99 23.39 59.00 43.70
Tangible Book Value Per Share
40.55 37.11 34.40 29.60 23.18
Shareholders’ Equity Per Share
42.21 38.78 36.09 31.39 25.09
Tax and Other Ratios
Effective Tax Rate
0.20 0.18 0.17 0.14 0.18
Revenue Per Share
41.73 39.70 38.80 38.06 29.05
Net Income Per Share
6.80 7.99 7.88 8.90 4.68
Tax Burden
0.80 0.85 0.86 0.88 0.86
Interest Burden
1.02 0.99 0.99 0.99 0.98
Research & Development to Revenue
0.02 0.02 0.02 0.02 0.02
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 0.01 0.02
Income Quality
1.41 1.31 1.24 0.88 1.36
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis